Cilostazol
Product Images NDC 54868-5411

5 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 54868-5411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cilostazol 100 mg (5411)

Cilostazol 100 mg (5411)
The label for Cilostazol tablets, 100 mg, from Physicians Total Care, Inc. The package contains 30 tablets. The label includes the NDC number 54868-5411, dosing instructions, storage conditions advising to keep below 30°C, and a caution that federal law prohibits dispensing without a prescription. Additional information includes lot number, expiration date, and barcode.*
FDA Label Image

Chemical Structure (Cilostazol Tablets Usp 1)

Chemical Structure (Cilostazol Tablets Usp 1)
Chemical structure of Cilostazol showing its molecular arrangement with labeled chemical bonds and atoms, including nitrogen-containing rings and oxygen substitutions, alongside the compound name Cilostazol.*
FDA Label Image

Graph (Cilostazol Tablets Usp 2)

Graph (Cilostazol Tablets Usp 2)
A line graph showing plasma concentration (ng/mL) versus time (hours) for Cilostazol and its metabolites 3,4-dehydro-cilostazol and 4'-trans-hydroxy-cilostazol. Cilostazol shows a peak concentration around 2-4 hours followed by a decline, while both metabolites have lower and more stable concentrations over 24 hours.*
FDA Label Image

Graph 2 (Cilostazol Tablets Usp 3)

Graph 2 (Cilostazol Tablets Usp 3)
A bar graph showing percent mean improvement in maximal walking distance at study end for eight randomized, double-blind, placebo-controlled clinical trials. The graph compares placebo, Cilostazol 50 mg b.i.d., and Cilostazol 100 mg b.i.d. across trials with varying durations and participant numbers.*
FDA Label Image

Logo (Cilostazol Tablets Usp 4)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.